Royalty Pharma Plc (RPRX) financials · rev $2.38B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Royalty Pharma Plc (RPRX) rev $2.38B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $2.38B | $2.26B |
| Operating Income | $1.56B | $1.29B |
| Net Income | $770.9M | $859.0M |
| EPS (Diluted) | $1.78 | $1.91 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $19.62B | $18.22B |
| Current Assets | $1.53B | $1.80B |
| Cash & Equivalents | $618.7M | $929.0M |
| Total Liabilities | $9.91B | $7.88B |
| Current Liabilities | $636.2M | $1.25B |
| Short-term Debt | $380.0M | $997.8M |
| Long-term Debt | $8.57B | $6.61B |
| Total Debt | $8.95B† | $7.61B† |
| Shareholders' Equity | $9.71B | $10.34B |
| Retained Earnings | $2.36B | $2.85B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $2.49B | $2.77B |
| Investing Cash Flow | -$1.61B | -$2.68B |
| Financing Cash Flow | -$1.19B | $361.1M |
| Net Change in Cash | -$310.3M | $452.0M |
FAQ
What is RPRX P/E and revenue?
Royalty Pharma Plc (RPRX) rev $2.38B.
What is RPRX revenue?
Royalty Pharma Plc last cached revenue is $2.38B (FY2025).
Is RPRX profitable?
Royalty Pharma Plc last cached net income is $770.9M (FY2025).
What are RPRX total assets?
Royalty Pharma Plc last cached total assets are $19.62B (FY2025).
What is RPRX free cash flow?
No cached cash-flow row for RPRX yet.
Not investment advice. Cached statements, not a live tape.